Skip to main content

September's Most Popular Stories

Published: 10/3/22
By Andrew Briskin

In case you missed them, below you’ll find our top five stories from September 2022. This month’s best stories cover a wide variety of topics including tech updates, foot health, new therapies, and more!

1. The Future of Diabetes Care – Artificial Intelligence, Telemedicine, and Automated Insulin Delivery

A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in diabetes believe is coming next in diabetes management.

2. New Methods for Type 1 Prevention

Preventing type 1 diabetes – the main goal for some who do not believe a cure is possible – would ultimately bring this ancient disease to its end. The world’s top diabetes researchers explained how innovative solutions, such as insulin powder and probiotics, could address T1D at its earliest stages. 

3. Type 2 Diabetes Remission – How is it Defined?

The term “type 2 diabetes remission” continues to spark debate in the diabetes community. At the EASD 2022 annual conference in Stockholm, experts explored this concept and what the term means for people with type 2 diabetes.

4. Diabetes and Foot Health

Having diabetes puts you at risk for problems with your feet. There are steps you can take to keep your feet healthy as recommended in the latest ADA Standards of Care.​ 

5. New Therapy Could Result in Weight Loss and Lower Glucose

Encouraging trial results from Novo Nordisk show that a new combination therapy in development could help people lower their A1C and weight dramatically. With the upcoming launch of several larger studies investigating the new therapy, find out if you can participate in one of these trials.

 

What do you think?

About the authors

Andrew Briskin joined the diaTribe Foundation in 2021 after graduating from the University of Pennsylvania with a degree in Health and Societies . Briskin is an Editor for diaTribe Learn.... Read the full bio »